The FDA has even authorized a drug created with cannabidiol for that purpose (Epidiolex). But the company only suggests it for two scarce varieties of childhood epilepsy identified as Lennox-Gastaut syndrome and Dravet syndrome.THC, the principal psychoactive constituent in the cannabis plant, has an especially minimal toxicity and the quantity whi